Display options
Cite
Okamoto H, Onodera K, Kamba R, et al. Treatment of spontaneous esophageal rupture (Boerhaave syndrome) using thoracoscopic surgery and sivelestat sodium hydrate. J Thorac Dis. 2018;10(4):2206-2212doi: 10.21037/jtd.2018.03.136.
Okamoto, H., Onodera, K., Kamba, R., Taniyama, Y., Sakurai, T., Heishi, T., Teshima, J., Hikage, M., Sato, C., Maruyama, S., Onodera, Y., Ishida, H., & Kamei, T. (2018). Treatment of spontaneous esophageal rupture (Boerhaave syndrome) using thoracoscopic surgery and sivelestat sodium hydrate. Journal of thoracic disease, 10(4), 2206-2212. https://doi.org/10.21037/jtd.2018.03.136
Okamoto, Hiroshi, et al. "Treatment of spontaneous esophageal rupture (Boerhaave syndrome) using thoracoscopic surgery and sivelestat sodium hydrate." Journal of thoracic disease vol. 10,4 (2018): 2206-2212. doi: https://doi.org/10.21037/jtd.2018.03.136
Okamoto H, Onodera K, Kamba R, Taniyama Y, Sakurai T, Heishi T, Teshima J, Hikage M, Sato C, Maruyama S, Onodera Y, Ishida H, Kamei T. Treatment of spontaneous esophageal rupture (Boerhaave syndrome) using thoracoscopic surgery and sivelestat sodium hydrate. J Thorac Dis. 2018 Apr;10(4):2206-2212. doi: 10.21037/jtd.2018.03.136. PMID: 29850124; PMCID: PMC5949456.
Copy Download .nbib Format: NLM
Share it on

J Thorac Dis. 2018 Apr;10(4):2206-2212. doi: 10.21037/jtd.2018.03.136.

Treatment of spontaneous esophageal rupture (Boerhaave syndrome) using thoracoscopic surgery and sivelestat sodium hydrate.

Journal of thoracic disease

Hiroshi Okamoto, Ko Onodera, Rikiya Kamba, Yusuke Taniyama, Tadashi Sakurai, Takahiro Heishi, Jin Teshima, Makoto Hikage, Chiaki Sato, Shota Maruyama, Yu Onodera, Hirotaka Ishida, Takashi Kamei

Affiliations

  1. Department of Gastroenterological Surgery, Graduate School of Medicine, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  2. Department of General Practitioner Development, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  3. Department of Surgery, Osaki Citizen Hospital, Osaki, Japan.
  4. Department of Surgery, Iwate Prefectural Central Hospital, Morioka, Japan.
  5. Department of Surgery, Sendai City Hospital, Sendai, Japan.

PMID: 29850124 PMCID: PMC5949456 DOI: 10.21037/jtd.2018.03.136

Abstract

BACKGROUND: The mortality rate of spontaneous esophageal rupture remains 20% to 40% due to severe respiratory failure. We have performed thoracoscopic surgery for esophageal disease at our department since 1994. Sivelestat sodium hydrate reportedly improves the pulmonary outcome in the patients with acute lung injury (ALI).

METHODS: We retrospectively evaluated the usefulness of thoracoscopic surgery and perioperative administration of sivelestat sodium hydrate for spontaneous esophageal rupture in 12 patients who underwent thoracoscopy at our department between 2002 and 2014.

RESULTS: The patient cohort included 11 males and one female (median age, 61 years). The lower left esophageal wall was perforated in all patients. Surgical procedures consisted of thoracoscopic suture and thoracic drainage in six patients, transhiatal suture and thoracoscopic thoracic drainage in five, and thoracoscopic esophagectomy and thoracic drainage in one. The median time from onset to surgery was 8 hours with a surgical duration of 210 minutes, blood loss 260 mL, postoperative ventilator management 1 day, intensive care unit (ICU) stay 5 days, and interval to restoration of oral ingestion 13 days. Postoperative complications included respiratory failure in four patients, pyothorax in three, and leakage in one. There was no instance of perioperative mortality. Regarding perioperative administration of sivelestat sodium hydrate, the postoperative arterial oxygen partial pressure-to-fractional inspired oxygen ratio (P/F) and C-reactive protein (CRP) levels in the administration group were significantly better than those in the non-administration group on postoperative days 4 (P=0.035) and 5 (P=0.037), respectively. In contrast, there was no significant difference between the groups in median time of ventilator management, ICU stay, oral ingestion following surgery, or hospital stay.

CONCLUSIONS: Thoracoscopic surgery obtained acceptable results in all patients, including two with a significant time elapse from onset to treatment. Furthermore, sivelestat sodium hydrate was suggested to help improve postoperative respiration and inflammatory response.

Keywords: Boerhaave syndrome; C-reactive protein (CRP); PaO2/FiO2 ratio; sivelestat; thoracoscopy

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

References

  1. Surg Today. 1997;27(9):793-800 - PubMed
  2. Am J Surg. 1981 May;141(5):531-3 - PubMed
  3. Bull Med Libr Assoc. 1955 Apr;43(2):217-40 - PubMed
  4. J Thorac Cardiovasc Surg. 2001 Jan;121(1):178-9 - PubMed
  5. Biosci Trends. 2016 May 23;10 (2):120-4 - PubMed
  6. Ann Thorac Surg. 1975 Oct;20(4):387-99 - PubMed
  7. Ann Thorac Surg. 2011 May;91(5):1552-5 - PubMed
  8. Biochem Biophys Res Commun. 1991 Jun 14;177(2):814-20 - PubMed
  9. Surg Today. 2013 Apr;43(4):361-6 - PubMed
  10. Crit Care Med. 2002 May;30(5 Suppl):S281-7 - PubMed
  11. Am Surg. 2013 Sep;79(9):902-8 - PubMed
  12. J Thorac Cardiovasc Surg. 1996 Dec;112(6):1533-40; discussion 1540-1 - PubMed
  13. Dis Esophagus. 2010 May;23(4):329-39 - PubMed
  14. Dis Esophagus. 2007;20(6):478-86 - PubMed
  15. J Thorac Dis. 2016 Dec;8(12 ):E1576-E1580 - PubMed
  16. Pulm Pharmacol Ther. 2004;17(5):271-9 - PubMed
  17. Ann Thorac Surg. 1989 May;47(5):689-92 - PubMed
  18. Dis Esophagus. 2010 Sep;23(7):565-71 - PubMed
  19. Eur J Pharmacol. 2002 Sep 6;451(1):1-10 - PubMed
  20. BMC Pulm Med. 2017 Nov 21;17 (1):148 - PubMed
  21. Int J Surg. 2013;11(1):64-7 - PubMed
  22. Ann Thorac Surg. 1999 Mar;67(3):818-20 - PubMed
  23. Am J Surg. 1982 Apr;143(4):495-503 - PubMed
  24. Ann Thorac Surg. 2004 Apr;77(4):1475-83 - PubMed
  25. Surg Endosc. 2002 Sep;16(9):1354-7 - PubMed
  26. Surg Endosc. 2011 Nov;25(11):3613-9 - PubMed
  27. Ann Thorac Surg. 1979 May;27(5):404-8 - PubMed

Publication Types